Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;9(6):e1675.
doi: 10.1002/mgg3.1675. Epub 2021 May 3.

Genetic analysis in Japanese patients with osteogenesis imperfecta: Genotype and phenotype spectra in 96 probands

Affiliations

Genetic analysis in Japanese patients with osteogenesis imperfecta: Genotype and phenotype spectra in 96 probands

Yousuke Higuchi et al. Mol Genet Genomic Med. 2021 Jun.

Abstract

Background: Osteogenesis imperfecta (OI) is a rare connective-tissue disorder characterized by bone fragility. Approximately 90% of all OI cases are caused by variants in COL1A1 or COL1A2. Additionally, IFITM5 variants are responsible for the unique OI type 5. We previously analyzed COL1A1/2 variants in 22 Japanese families with OI through denaturing high-performance liquid chromatography screening, but our detection rate was low (41%).

Methods: To expand the genotype-phenotype correlations, we performed a genetic analysis of COL1A1/2 and IFITM5 in 96 non-consanguineous Japanese OI probands by Sanger sequencing.

Results: Of these individuals, 54, 41, and 1 had type 1 (mild), type 2-4 (moderate-to-severe), and type 5 phenotypes, respectively. In the mild group, COL1A1 nonsense and splice-site variants were prevalent (n = 30 and 20, respectively), but there were also COL1A1 and COL1A2 triple-helical glycine substitutions (n = 2 and 1, respectively). In the moderate-to-severe group, although COL1A1 and COL1A2 glycine substitutions were common (n = 14 and 18, respectively), other variants were also detected. The single case of type 5 had the characteristic c.-14C>T variant in IFITM5.

Conclusion: These results increase our previous detection rate for COL1A1/2 variants to 99% and provide insight into the genotype-phenotype correlations in OI.

Keywords: COL1A1; COL1A2; IFITM5; Osteogenesis imperfecta; variant.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1
FIGURE 1
Variant spectra of COL1A1 and COL1A2. Symbols above the box represent the variants in the mild OI group. Symbols below the box represent the variants in the moderate‐to‐severe OI group. Aligned symbols represent the same variant

Similar articles

Cited by

References

    1. Ackermann, A. M. , & Levine, M. A. (2017). Compound heterozygous mutations in COL1A1 associated with an atypical form of type I osteogenesis imperfecta. American Journal of Medical Genetics Part A, 173(7), 1907–1912. 10.1002/ajmg.a.38238 - DOI - PubMed
    1. Adzhubei, I. A. , Schmidt, S. , Peshkin, L. , Ramensky, V. E. , Gerasimova, A. , Bork, P. , Kondrashov, A. S. , & Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7(4), 248–249. 10.1038/nmeth0410-248 - DOI - PMC - PubMed
    1. Aoki, K. , & Wada, Y. (1988). Outcome of the patients detected by newborn screening in Japan. Pediatrics International, 30(4), 429–434. 10.1111/j.1442-200X.1988.tb02533.x - DOI - PubMed
    1. Bardai, G. , Moffatt, P. , Glorieux, F. H. , & Rauch, F. (2016). DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporosis International, 27(12), 3607–3613. 10.1007/s00198-016-3709-1 - DOI - PubMed
    1. Barnes, A. M. , Ashok, A. , Makareeva, E. N. , Brusel, M. , Cabral, W. A. , Weis, M. A. , Moali, C. , Bettler, E. , Eyre, D. R. , Cassella, J. P. , Leikin, S. , Hulmes, D. J. S. , Kessler, E. , & Marini, J. C. (2019). COL1A1 C‐propeptide mutations cause ER mislocalization of procollagen and impair C‐terminal procollagen processing. Biochimica Et Biophysica Acta (BBA) ‐ Molecular Basis of Disease, 1865(9), 2210–2223. 10.1016/j.bbadis.2019.04.018 - DOI - PMC - PubMed

Publication types

LinkOut - more resources